Baby Aspirin Misses Mark for Primary Cardiovascular Prevention in CKD

(MedPage Today) -- DENVER -- Daily low-dose aspirin did not significantly reduce major vascular events in adults with chronic kidney disease (CKD), the randomized ATTACK trial showed. Over a mean follow-up of 3.1 years, 2.4% of adults with CKD...